Skip to main content

Table 2 IBS and comorbidity-related costs of health care measured in Norwegian Kroner (NOK) in the six-month follow-up period.

From: How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice

Type of health resource IBS-related costs Comorbidity-related costs p-values *
Consultations 169 (610)
0 (0-5520)
1315 (1915)
539 (0-12688)
P < 0.001
Hospitalisations 710 (6413)
0 (0-58260)
10302 (27330)
0 (0-174780)
P < 0.001
Medications 47 (261)
0 (0-2785)
2999 (6796)
1544 (0-74634)
P < 0.001
Alternative products 26(127)
0 (0-1110)
238(544)
5 (0-4000)
P < 0.001
Total 1049(6574)
0 (0-60468)
14856(30570)
3190 (0-193355)
P < 0.001
  1. * Wilcoxon test due to skewed data.
  2. Results are given both as mean (SD) and median with range (italic). €1 equals NOK 8.